10x Genomics Introduces New Chromium X Series for Single Cell Analysis

July 14, 2021 at 8:01 AM EDTPDF Version Million-Cell Experiments Routinely Accessible for the First Time PLEASANTON, Calif., July 14, 2021 (GLOBE NEWSWIRE) — Building on its industry leading position in single cell analysis, 10x Genomics (NASDAQ: TXG) today announced commercial availability of its new Chromium X Series, a next-generation platform for single cell analysis.... Read more

Illumina to Announce Second Quarter 2021 Financial Results on Thursday, August 5, 2021

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for the second quarter 2021 following the close of market on Thursday, August 5, 2021. On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern Time) Francis deSouza, President and Chief Executive Officer, and Sam Samad, Chief Financial Officer, will host... Read more

Xylem To Release Second Quarter 2021 Financial Results On August 3, 2021

RYE BROOK, N.Y.–(BUSINESS WIRE)–Jul. 13, 2021– Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, will release its second quarter 2021 results at 6:55 a.m. (ET) on Tuesday, August 3, 2021. At 10:00 a.m. (ET), Xylem’s senior management team will host a conference call with... Read more

Thermo Fisher Scientific and My Green Lab Collaborate to Expand Use of ACT Label in Driving Environmentally Sustainable Lab Practices

Thermo Fisher Scientific and My Green Lab Collaborate to Expand Use of ACT Label in Driving Environmentally Sustainable Lab Practices 1,200+ products to be identified for environmentally friendly capabilities and sustainability objectives WALTHAM, Mass., July 13, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced an expansion of its... Read more

Thermo Fisher Scientific To Showcase Investments and Innovation at DCAT Week 2021

Thermo Fisher Scientific To Showcase Investments and Innovation at DCAT Week 2021 Strategic investments over the last two years expand global capabilities to support advanced therapies and large molecule development and manufacturing WALTHAM, Mass., July 12, 2021 /PRNewswire/ — This week, Thermo Fisher Scientific will highlight its investments and innovations over the past 12 months across its... Read more

GE Healthcare to Offer End-To-End Deep Learning Solutions with Spectronic Medical to Improve Accuracy for Radiation Oncology Treatment

Chicago/Helsingborg, Sweden July 9, 2021:  GE Healthcare announces the integration of Spectronic Medical AB AI-based software[1] for more precise cancer treatment planning. This AI solution, in combination with GE Healthcare’s industry leading AIR Recon DL technology, enables MR-only based radiotherapy planning for better soft tissue differentiation than traditional CT, so clinicians can better direct radiotherapy.... Read more

WHO guidelines now include Roche’s diagnostic tests in expanded effort to eliminate tuberculosis by providing patients greater access to timely diagnosis

Tuberculosis is a disease of poverty, and economic distress with 1.4 million deaths annually1 and the growing challenge of drug resistance is adding to the global health crisis WHO guidelines support the expansion of tuberculosis diagnostics in resource-limited countries, enabling patients to receive timely diagnosis leading to proper treatment, which benefits their recovery and slows... Read more

FBI Approves Thermo Fisher Scientific's Rapid DNA Solution for use in Law Enforcement Booking Stations

FBI Approves Thermo Fisher Scientific’s Rapid DNA Solution for use in Law Enforcement Booking Stations Applied Biosystems RapidHIT ID DNA Booking System enables seamless integration of Rapid DNA into the law enforcement booking agency process SAN FRANCISCO, July 8, 2021 /PRNewswire/ — The U.S. Federal Bureau of Investigation (FBI) has approved Thermo Fisher Scientific’s Applied Biosystems... Read more